Articles and Updates

We have been following this stock for 6 months, but discouraged from buying because of the ever growing stock price. But the story is great and we just had to hop on!

We sold whole AI & Big Data ETF. We feel the valuations of AI related companies are getting more out of hand and it’s starting to feel more like a bubble. We rather watch from the courtside than be on the field at this point; good entertainment.

Sold our position in AlzChem. The original reasoning for purchase turned out to be false and the momentum didn’t continue. This was a short term bet that didn’t work out.

Hopped on the AI train with a semi-focused ETF purchase. This ETF has mainly the big American players in the tech field.

Our holding in Kempower has shrunk to a size that no longer plays any significant role in the portfolio performance. We don’t want to buy more, thus selling is the right choice.

There is a good momentum in AlzChem at the moment and the business has very substantial tainwind from the market. This is a short term position only as we try to benefit from the momentum.

We feel that the weight in S&P 500 is still too small, but we will increase it in the future. We try to buy it incrementally in order to reduce timing risk.

The valuation of Admicon has risen too much compared to the performance of the business. Thus, we take a pause from Admicon and think next where we want to invest that money into.

During the past 4 months we have been able to collect 475 euros of cash in the kids’ piggy banks. This new cash investment in the portfolio represents little over 4 % of the portfolio value.